7774 — Japan Tissue Engineering Co Balance Sheet
0.000.00%
Last trade - 00:00- ¥29bn
- ¥25bn
- ¥3bn
Annual balance sheet for Japan Tissue Engineering Co, fiscal year end - March 31st, JPY millions except per share, conversion factor applied.
2020 March 31st | 2021 March 31st | 2022 March 31st | 2023 March 31st | 2024 March 31st | |
|---|---|---|---|---|---|
| Period Length: | — | — | — | — | — |
| Source: | Yuho | Yuho | Yuho | Yuho | Yuho |
| Standards: | JAS | JAS | JAS | JAS | JAS |
| Status: | Final | Final | Final | Final | Final |
| Cash and Equivalents | |||||
| Cash and Short Term Investments | 5,751 | 5,276 | 4,933 | 4,135 | 4,266 |
| Net Total Accounts Receivable | |||||
| Net Total Receivables | 682 | 822 | 496 | 576 | 609 |
| Total Inventory | |||||
| Prepaid Expenses | |||||
| Total Other Current Assets | |||||
| Total Current Assets | 6,817 | 6,545 | 5,946 | 5,211 | 5,339 |
| Gross Property, Plant And Equipment | |||||
| Accumulated Depreciation | |||||
| Net Property, Plant And Equipment | 1,621 | 1,555 | 1,614 | 1,567 | 1,511 |
| Net Intangible Assets | |||||
| Long Term Investments | |||||
| Other Long Term Assets | |||||
| Total Assets | 8,452 | 8,119 | 7,598 | 6,883 | 6,989 |
| Accounts Payable | |||||
| Accrued Expenses | |||||
| Notes Payable / Short Term Debt | |||||
| Current Portion of Long Term Debt / Capital Leases | |||||
| Total Other Current Liabilities | |||||
| Total Current Liabilities | 784 | 919 | 897 | 911 | 874 |
| Capital Lease Obligations | |||||
| Total Long Term Debt | |||||
| Total Debt | |||||
| Total Other Liabilities | |||||
| Total Liabilities | 821 | 955 | 932 | 946 | 908 |
| Common Stock | |||||
| Additional Paid In Capital | |||||
| Retained Earnings (Accumulated Deficit) | |||||
| Treasury Stock | |||||
| Other Equity | |||||
| Total Equity | 7,631 | 7,164 | 6,666 | 5,937 | 6,080 |
| Total Liabilities & Shareholders' Equity | 8,452 | 8,119 | 7,598 | 6,883 | 6,989 |
| Total Common Shares Outstanding |